Find Inside: Today's Trade Update Plus Your New Bounce Profile With A Huge P.R. And Breakout Potential

Find Inside: Today's Trade Update Plus Your New Bounce Profile With A Huge P.R. And Breakout Potential New Stock Profile: Mota Ventures Corp. (OTC: PEMTF) (CSE: MOTA) (FSE: 1WZ1) June 10th, 2020 FierceAnalyst Member, Let's keep the winners going! Today's profile (FUV) surged approximately 31% intraday from an open of $3.41 to a high of $4.479. With today's high, FUV ended up hitting a new 52-week high! This will be a profile to keep on your radar in the short-term as it could keep climbing in the days ahead. Now, back to the main event: Your new stock profile: Mota Ventures Corp. (OTC: PEMTF) Today PEMTF released bombshell revenue news which you will read below. Could this be perfect timing? CBD and psi*loc*ybin ("PSI"), otherwise known as medicinal mushrooms, have been hot topics when it comes to treating various health issues. CBD, the non-psycho active compound of marijuana, is said to treat insomnia, depression, anxiety, inflammatory conditions, chronic pain, and even more serious issues such as diabetes and epilepsy. The chronic pain market alone is massive for CBD companies to cater to, with the CDC estimating that 1 in 5 Americans suffer from it! Leading scientists, academic institutions and government administrations are also turning their attention to the benefits of PSI as a potential treatment for the global problems of mental health and end of life care. PSI is being studied to treat depression, addiction, and even Alzheimer's disease! This is very thrilling stuff as the potential for what this compound can do in medicine is breathtaking. The most exciting part is that pharma giants are now becoming more interested in including CBD and PSI in their quests to produce drugs that can help people all while create massive profits. This brings me to your new stock profile: Mota Ventures Corp. (OTC: PEMTF) PEMTF is an established eCommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe. The company is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. PEMTF is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of the company. PEMTF - Another Huge Bounce Play! Shares of PEMTF were as high a 58 cents just this past January. The stock has been climbing back in recent weeks, moving from under 20 cents at the end of March to 37 cents this past week. As Wall Street continues to learn about all of PEMTF's developments, share prices could quickly zoom back to previous highs and even surpass them! PEMTF - The Next Leader In Natural Medicine In the United States, PEMTF sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its First Class CBD and Nature's Exclusive brands. First Class CBD is one of the largest U.S. based online retailers of CBD products. It provides CBD products to consumers in both the US and Europe. Highlights include: - Leader in online CBD sales in North America - US grown CBD hemp - Current customer base 142,000 customers -with additional leads of over 424,000 potential new customers - 2019 Sales of $28.7M*/ EBITDA of $3.58M (CAD using Bank of Canada average exchange rate for 2019 of $1.3269) PEMTF launched the Pure Herbal Immunity Blend under its First Class CBD brand in March of 2020. The all-natural Immunity Blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano. Due to customer demand for pure and efficacious products to support the immune system, the Company has also launched an Immune CBD oil, along with an Elderberry Gummy product. The new Immune CBD product contains CBD, B3, B12, Vitamin C and Zinc. Based on the success of the launch, First Class will be increasing marketing efforts throughout the US. Since the launch in March, the company has acquired over 5,500 new customers seeking natural solutions to help support their family’s immune systems. The popularity of the primary product has yielded an average initial order value for immune support customers of $189.00! “The Immune Support product launch has been the most successful product launch in the history of our First Class brand. E-Commerce is a fast-moving sector, especially during these very unique times we are facing today. Our ability as a company to quickly develop and launch new products to meet market demand is a testament to our expertise. I am very excited by the reception we have received to date for our Immune Line of products. I project demand for the line will continue through Q2 and be a significant driver to our growth for 2020,” said CEO Ryan Hoggan. PEMTF's Natures Exclusive offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CDB skin serum and CBD coffee. Enormous Revenue of C$29 Million Last Year! "The acquisition of Nature's Exclusive is a milestone for the company and aligns with our goal of becoming a vertically integrated CBD brand. The revenue they generated in 2019 positions us to compete with the largest cannabis companies in the world, and the infrastructure they have in place is a key building block our organization can use to expand further in the [United States] and Europe," said President Joel Shacker. Natures Exclusive has also recently launched a CBD hand sanitizer with 70% ethyl alcohol as its active ingredient, as well as, CBD isolate and Vitamin E. It is initially offered only to consumers in the United States. "This product offering will allow us to reach a new client base, while generating significant gross margin and attracting clients to our other product lines," said Ryan Hoggan, CEO of PEMTF. "I am very pleased with the continued strength of our new customer acquisition month-to-date as demand remains strong for our CBD and immune products. We anticipate similar demand for our new CBD Hand Sanitizer product due to the limited availability of sanitizer through current retail and eCommerce channels. This product offering will allow us to reach a new client base, while generating significant gross margin and attracting clients to our other product lines," said Ryan Hoggan, CEO of PEMTF. C-virus has created a major shift in consumer behaviors and hand sanitizer is expected to be a staple for years to come! PEMTF acquired the Sativida brand on March 26, 2020. Sativida is an online retailer in Spain and Mexico, with distribution channels in Spain, Portugal, Austria, Germany, France and the UK. Sativida is a leading European based online retailer of CBD products. Highlights of this brand include: - Current distributor of CBD products in Spain, Portugal, Austria, Germany, France and the United Kingdom - One of the top search-ranked online retailer in Spain and Mexico - Award winning product line known for its minimal heavy metal content and accurate CBD levels - 100% organic products - 2019 revenue $560,000 / 64% gross margins Sativida is a leading European based online retailer of CBD products. It is a current distributor of CBD products in Spain, Portugal, Austria, Germany, France and the United Kingdom. The brand offers award winning 100% organic CBD oils and cosmetics. The company's award winning product line is known for its minimal heavy metal content and accurate CBD levels and has been one of the top search-ranked online retailers in Spain and Mexico. PEMTF's Columbian operations are Ihuana, a licensed Colombian CBD producer. Highights include: - 2.5 hectares site - Completed research and development facility - Access to natural water reservoirs and minimal energy costs - Located 2 hours outside of Bogota - Ideal growing conditions year round - Low cost production - Fully licensed for cultivation of medical non psy*cho*active cannabis (CBD) as well as the manufacturing and exportation of cannabis derivatives (extracts) - Positioned to produce branded CBD products to the global market at a fraction of the cost of local producer - Officially established at the beginning of 2017, Ihuana is made up by an interdisciplinary team that has achieved significant steps to structure a project with high economic, scientific and human potential. Their mission is to provide patients and the pharmaceutical industry with raw material and final product with high quality cannabis. The company’s vision is to be the leaders of the cannabis market, in regards to innovation, cultivation technologies, scientific research and compound extraction.   PEMTF - Revenues In The Millions! PEMTF recently announced record revenues for the month of April totaling C$3,818,000, representing an increase of 39% compared to April 2019. Expenses totaled C$3,609,000, representing a Gross Profit of C$209,000 for the month. The Company credits this success to its’ online customer acquisition strategy, which is capitalizing on the strong consumer demand for natural health solutions, resulting in an interim record number of customer acquisitions for the Nature’s Exclusive brand, as well as, new customers for the immune support category introduced in March 2020. For the month of April, PEMTF acquired 17,996 new customers. This represents an increase of 48% compared to April 2019. In April, the Company also experienced strong demand from customers enrolling in a subscription, totaling of 14,091 new subscribers during the month. This represents a new subscriber increase of 78% compared to April 2019. 2019 Calendar Year Audit of Nature's Exclusive Brand Found - Revenue of Cdn$29,034,000 - Net income of $3,505,000 - Achieved a margin of over 12% The 2019 financial results for the Nature's Exclusive brand is a strong indicator of the power of PEMTF’s eCommerce business model. This growth continued into 2020. For the months January through April 2020, the Company has generated revenue of C$13,968,000 with related expenses of C$13,514,000. Revenue has increased 188% for this time period over the same period during 2019! The Company's customer acquisition and subscription retention strategies are yielding benefits through the year and into May where the Nature's Exclusive brand has acquired over 17,613 customers from May 1st through May 18th. With over 60% of these customers electing into a subscription, the Company expects reduced costs in the following months, as customer acquisition expense is a one-time cost per customer. PEMTF - Looking Ahead at the Highly Buzzed About PSI Space Many are now asking if shrooms, or PSI, will be the next big thing in plant medicine. The new buzzed topic is psychedelic medicine and this "mush rush" ... this "shroom boom" could send early players like PEMTF in the space soaring. PSI, or better known as medicinal mushrooms, could be the key to treating many mental disorders in the world. This includes depression, anxiety, and even addiction. Several clinical trials in the last half-decade have concluded that PSI can effectively treat anxiety, depression, and other conditions. The federal government is now seriously considering legalizing this natural psychedelic as an adjunct to therapy! PEMTF has come to terms to acquire Verrian, a leading established company in the psychedelic medicine sector. Verrian owns and operates an EU-GMP, ISO 14001 compliant 110,000 sq. ft. pharmaceutical manufacturing facility in Radebuel, Germany, which it purchased from a major global pharmaceutical manufacturer in 2019. Both the facility and equipment are independently appraised at C$10,600,000, including an analytical laboratory, and full pharmaceutical manufacturing suite. Verrian is composed of three distinct business segments: - Pharmaceutical Manufacturing - A portfolio of medical & wellness products - Phyto API - API creation from medical plants - Analytical Testing - European Medicine Agency Standards Verrian's singular focus is rewiring the mind to overcome addiction through natural medicine. Specifically, the micro dosing of PSI demonstrates potential to remove the dopamine reward of addictive substances, potentially diminishing the desire for addictive substances, thereby reducing or eliminating the need for the addictive substance. The company's product development pipeline is incredibly strong with two products named PSI Gen and PSI Gen+, which are both natural PSI extracts from organic mushrooms combined with metabolism-enhancing natural herbs. In addition to treatments for opioids, new studies have demonstrated successful PSI treatments for both alcoholism and depression, substantially increasing the market size of potential patients. According to Marketdata, the United States market for alcohol and drug addiction rehab will be worth $42 million in 2020, with over 15,000 private treatment facilities and growing! "Our acquisition of Verrian is another step forward in executing our vision to use our powerful eCommerce platform for new and innovative natural health products. While we continue to grow and expand our CBD business units, we will also be ready to fully commercialize the technology created by Verrian," said CEO Ryan Hoggan. He added, "I am extremely excited at the opportunity to acquire an established Psychedelic medicine company in Europe. As an innovative company, Mota always seeks to be a leader in the natural health space and we see the psychedelic medicine market becoming a major part of the industry. This acquisition allows us to have first mover advantage in the Psychedelic market, and Mota's existing distribution network will be ready to capitalize on the opportunity once regulation has been put in place." "Based on the studies currently underway, psychedelics and psychedelic-assisted psychotherapy are promising new paradigms for the treatment of neuropsychiatric disorders," says Dr. Michael Ehlers, an advisor to Field Trip Psychedelics, as quoted by Forbes. "Some studies are showing that psychedelic-assisted psychotherapy using PSI and MDMA to treat depression and PTSD are helping patients manage symptoms of these conditions. In some instances, these treatments are leading to remission of the condition itself."   PEMTF - The Colossal CBD Opportunity According to the Brightfield Group, the hemp-CBD market alone is estimated to hit $22 billion by 2022. CBD is now considered one of the hottest new health and wellness trends. It is a natural compound found in cannabis and hemp and does not cause a high like the compound THC. Changes to state and federal laws have led to a rise in the production of CBD-infused products. A Gallup survey has found that 1 in 7 adults are now using CBD products! 35% of U.S. adults say they are not familiar with it, while another 50% say they are aware of it but do not use it. There is still a significant chunk of America that could be on its way to using CBD. The market potential is a monster. PEMTF's Immune Support line is gaining interest from customers that historically were hesitant to purchase CBD, but are now interested in the Immune products and the potential anti-inflammatory benefits of CBD. Many studies agree that CBD can strengthen the immune system. - CBD has anti-inflammatory properties, which can reduce the immune system’s inflammatory response. Inflammation is a vital response that isolates infected areas and prevents toxins from spreading. - CBD can promote apoptosis, or cellular death. - CBD can prevent proliferation, or rapid cellular growth. - CBD can modulate or suppress the function and secretion of cytokines. Cytokines are large groups of proteins, secreted by specific cells in your immune system. Their function is to signal molecules that regulate your body’s immunity, inflammation, and white blood cell production. - CBD can also suppress the production of chemokine, which is a group of cytokines that act as chemoattractants. They lead immune cells to an infection site so that the white blood cells can attack and destroy invading microbes. - CBD can suppress T-cell production and function, ultimately suppressing the immune system’s ability to remember foreign invaders. SOURCE: [( CBD Is Also Seeing Monumental Demand In Europe! In Europe alone, the CBD market is on course to grow 400% over the next four years, according to the Brightfield Group. According to New Frontier Data‘s EU CBD Consumer Report: 2019 Overview, 46% of Europeans view CBD favorably, and up to 77% of surveyed respondents also believe CBD should be accessible in some way.   Press Release Published: June 10, 2020 at 4:05 a.m. ET Mota Ventures Reports Monthly Revenues of Cdn$5,141,000 for Natures Exclusive, Highest in the History of the Brand, Representing, an Increase of 110% from May 2019 June 10, 2020 (ACCESSWIRE via COMTEX) -- VANCOUVER, BC, CANADA / ACCESSWIRE / June 10, 2020 / Mota Ventures Corp. (CSE:MOTA) (FSE:1WZ1)(OTC PINK:PEMTF) (the "Company") the Company's subsidiary, Nature's Exclusive, an eCommerce provider of CBD products to consumers in the United States, is pleased to announce an all-time monthly revenue record achieved during May 2020. Revenue for the month of May totaled Cdn$5,141,000, representing an increase of 110% compared to May 2019. Expenses totaled Cdn$4,992,000 for the month, representing a gross profit of Cdn$149,000 for May 2020. The Company's investment in customer acquisition continues to yield benefits with the brand acquiring 23,141 new customers during the month of May 2020. The Company's strong ability to continue to acquire and retain new customers for its products continues to accelerate. As consumers continue to seek natural health product solutions, the Nature's Exclusive brand is well positioned to offer consumers quality and convenience. The Company's Nature's Exclusive brand offers a CBD hemp-oil formulation intended to provide users with the therapeutic benefits that hemp may offer. The hemp oil used in the products is derived from hemp grown and cultivated in the United States. The extraction process is designed to maintain all the beneficial qualities that hemp may offer. Nature's Exclusive offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee. "I am very pleased our Nature's Exclusive brand achieved another monthly sales record. We continued to expand in the United States, and our outlook for the second half of fiscal 2020 is very positive. We remain on track to achieve our goals for 2020 despite the recent economic turmoil," stated Ryan Hoggan, CEO of the Company. The Company cautions that figures for revenue, expenses and margin generated from the sale of Nature's Exclusive products in fiscal year 2020 have not been audited, and are based on calculations prepared by management. Actual results may differ from those reported in this release once these figures have been audited. These figures were translated from US dollars into Canadian dollars using the Bank of Canada monthly average exchange rate of US$1.00:Cdn$1.397 for May 2020 and US$1.00:Cdn$1.3459 for May 2019. THE BOTTOM LINE: PEMTF released huge revenue news that has the potential to drive shareholder value. The stock more than doubled since March lows when it soared from under 20 cents to approximately 37 cents this past Tuesday. With such an exciting story, PEMTF is looking like a ground-floor situation at these levels and there could be tremendous upside ahead! Start your own research at: [www.motaventuresco.com](. Sincerely, Fierce Analyst | Jaks Swift Editorial Writer I am not a licensed financial adviser. All potential percentage gains are based on from the low to the high of day. Fierce full disclosure is to be read and fully understood before using Fierce's website, or joining Fierce's email or text list. By viewing Fierce's website and/or reading Fierce's email or text newsletter you are agreeing to -> [( Stock Wire News (stock wire news . com) is owned by Stock News Wire LLC, a limited liability company. A member of Stock News Wire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com (“SCF”), an interest in the limited liability company that owns and operates fierce investor . com (“FI”), and an interest in the limited liability company that owns and operates stock street wire . com (SSW). From time to time, Stock Wire News, SCF, FI and/or SSW publicly disseminate information about a company via website, email, SMS and other points of media. Stock Wire News (stock wire news . com) is owned by Stock News Wire LLC, a limited liability company. A member of Stock News Wire, LLC owns an interest in the limited liability company that owns and operates small cap firm . com (“SCF”), an interest in the limited liability company that owns and operates fierce investor . com (“FI”), and an interest in the limited liability company that owns and operates stock street wire . com (SSW). From time to time, Stock Wire News, SCF, FI and/or SSW publicly disseminate information about a company via website, email, SMS and other points of media. Pursuant to an agreement between Fierce Investor (FI) and StockWireNews LLC, FI has been hired for a period beginning on 6/10/20 and ending on 6/11/20 to publicly disseminate information about (PEMTF) via Website, Email and SMS. We were paid fifteen thousand USD via ACH. We own zero shares of (PEMTF). A member of StockWireNews LLC owns an interest in Fierce Investor. Pursuant to an agreement between StockWireNews LLC and Electrik Dojo, LLC, StockWireNews has been hired for a period beginning on 6/10/20 and ending on 6/11/20 to publicly disseminate information about (PEMTF) via Website, Email and SMS. We have been paid seventy-five thousand USD via bank wire transfer. We own zero shares of (PEMTF). Pursuant to an agreement between Fierce Investor (FI) and StockWireNews LLC, FI has been hired for a one day period on 6/10/20 to publicly disseminate information about (FUV) via Website, Email and SMS. We were paid five thousand USD via ACH. We own zero shares of (FUV). A member of StockWireNews LLC owns an interest in Fierce Investor. Pursuant to an agreement between StockWireNews LLC and Venado Media, LLC, StockWireNews has been hired for a one day period on 6/10/20 to publicly disseminate information about (FUV) via Website, Email and SMS. We have been paid twenty-seven thousand five hundred USD via bank wire transfer. We own zero shares of (FUV).   Fierce | 539 W Commerce St, Dallas, TX 75208 [Unsubscribe {EMAIL}]( [Update Profile]( | [About Constant Contact]( Sent by jaks@fierceanalyst.net